Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jan 15, 2019; 11(1): 17-27
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.17
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.17
Preoperative levels | Postoperative levels | |||||||||||
Overall survival | Disease-free survival | Overall survival | Disease-free survival | |||||||||
HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | HR | 95%CI | P | |
CEA (> 5 ng/mL) | 2.02 | 1.48-2.73 | < 0.0001 | 1.70 | 1.30-2.20 | 0.0002 | 2.30 | 1.59-3.23 | < 0.0001 | 1.89 | 1.36-2.56 | 0.0002 |
CA19-9 (> 37 IU/mL) | 1.59 | 1.11-2.23 | 0.0125 | 1.76 | 1.32-2.32 | 0.0002 | 2.61 | 1.72-3.81 | < 0.0001 | 2.76 | 1.96-3.78 | < 0.0001 |
- Citation: Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27
- URL: https://www.wjgnet.com/1948-5204/full/v11/i1/17.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.17